Atlas Trials

High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

Clinical trial NCT03128359 · COMPLETED

Trial details

NCT number
NCT03128359
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute LeukemiaChronic Lymphocytic Leukemia/Small Lymphocytic LymphomaChronic Myelogenous Leukemia, BCR-ABL1 PositiveDiffuse Large B-Cell LymphomaFollicular LymphomaGraft Versus Host DiseaseHodgkin LymphomaMantle Cell LymphomaMarginal Zone LymphomaMyelodysplastic SyndromeMyeloproliferative NeoplasmRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes
Start date
2017-05-30
Primary completion
2020-08-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.